Novo Nordisk to Invest $130 Million for New Labs for Diabetes R&DBy
Novo Nordisk plans to invest approximately 750 million Danish kroner ($130 million US) in new laboratories at the company’s R&D campus in MÃ¥lÃ¸v, Denmark. Construction has started, and the new laboratory facility is expected to be ready for occupation in early 2016.
The new facility, Diabetes Research House, will accommodate approximately 350 employees. During the construction phase, the project is expected to generate more than 1,000 jobs outside Novo Nordisk.
The facility comprises two laboratory wings, a middle building with office space, and an auditorium seating 450 people. The facility will have a floorage of 16,500 square meters distributed on three stories.
Novo Nordisk opened its R&D campus in MÃ¥lÃ¸v in 1991 with about 300 employees. Today, the campus accommodates more than 2,300 employees. Globally, about 5,000 employees are involved in research and development activities at Novo Nordisk’s R&D units in Denmark, the US, and China.
Source: Novo Nordisk